SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-019151
Filing Date
2020-07-30
Accepted
2020-07-30 06:30:52
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0620_lanternpharma.htm 10-Q 368836
2 CERTIFICATION f10q0620ex31-1_lantern.htm EX-31.1 8521
3 CERTIFICATION f10q0620ex31-2_lantern.htm EX-31.2 17442
4 CERTIFICATION f10q0620ex32-1_lantern.htm EX-32.1 6173
5 CERTIFICATION f10q0620ex32-2_lantern.htm EX-32.2 6184
  Complete submission text file 0001213900-20-019151.txt   1920732

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ltrn-20200630.xml EX-101.INS 227996
7 XBRL SCHEMA FILE ltrn-20200630.xsd EX-101.SCH 27922
8 XBRL CALCULATION FILE ltrn-20200630_cal.xml EX-101.CAL 24684
9 XBRL DEFINITION FILE ltrn-20200630_def.xml EX-101.DEF 96774
10 XBRL LABEL FILE ltrn-20200630_lab.xml EX-101.LAB 168865
11 XBRL PRESENTATION FILE ltrn-20200630_pre.xml EX-101.PRE 145423
Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201
Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136
Lantern Pharma Inc. (Filer) CIK: 0001763950 (see all company filings)

IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39318 | Film No.: 201059063
SIC: 2834 Pharmaceutical Preparations